Results 41 to 50 of about 5,658 (197)

Quantifying lymphocyte vacuolization serves as a measure of CLN3 disease severity

open access: yesJIMD Reports, 2020
Background The CLN3 disease spectrum ranges from a childhood‐onset neurodegenerative disorder to a retina‐only disease. Given the lack of metabolic disease severity markers, it may be difficult to provide adequate counseling, particularly when novel ...
Willemijn F. E. Kuper   +11 more
doaj   +1 more source

Neurodegeneration and Epilepsy in a Zebrafish Model of CLN3 Disease (Batten Disease). [PDF]

open access: yesPLoS ONE, 2016
The neuronal ceroid lipofuscinoses are a group of lysosomal storage disorders that comprise the most common, genetically heterogeneous, fatal neurodegenerative disorders of children.
Kim Wager   +5 more
doaj   +1 more source

Drug-induced hyperthermia with rhabdomyolysis in CLN3 disease

open access: yesEuropean Journal of Paediatric Neurology, 2022
CLN3 disease (MIM# 204200), the most prevalent of the neuronal ceroid lipofuscinoses (NCL), is an autosomal recessive disorder with juvenile onset characterized by blindness, epilepsy, dementia, psychiatric manifestations, and motor deterioration. Problems related to behavior, emotions and thought are among the main features.
A, Savvidou   +5 more
openaire   +2 more sources

A. gossypii smFISH CLN3

open access: yes, 2023
smFISH Data of the A. gossypii cyclin CLN3, supporting the work "The Role of RNA Phase Separation in Noise Suppression". Each of the 15 hyphae imaged have four associated data sets: the raw (deconvolved) image data, detected RNA locations, hyphal masks, and nuclear masks.
openaire   +2 more sources

Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease

open access: yesNeurobiology of Disease, 2006
Batten disease, a lysosomal storage disorder, is caused by mutations in the CLN3 gene. The Cln3-knockout (Cln3−/−) mouse model of the disease exhibits many characteristic pathological features of the human disorder.
Attila D. Kovács   +2 more
doaj   +1 more source

Dual Repressive Function by Cip1, a Budding Yeast Analog of p21, in Cell-Cycle START Regulation

open access: yesFrontiers in Microbiology, 2020
Cip1, a newly identified yeast analog of p21, is a Cln3-CDK inhibitor that negatively regulates cell-cycle START. However, its function remains poorly understood.
Pan Li   +11 more
doaj   +1 more source

The yeast Cln3 protein is an unstable activator of Cdc28. [PDF]

open access: yesMolecular and Cellular Biology, 1993
The Cln3 cyclin homolog of Saccharomyces cerevisiae functions to promote cell cycle START for only a short time following its synthesis. Cln3 protein is highly unstable and is stabilized by C-terminal truncation. Cln3 binds to Cdc28, a protein kinase catalytic subunit essential for cell cycle START, and Cln3 instability requires Cdc28 activity.
F R, Cross, C M, Blake
openaire   +2 more sources

Cdk-phosphorylation of the Cln3 C-terminus is required for its degradation.

open access: yes, 2012
(A) Mutation of Cdk consensus sites stabilizes Cln3. Cycloheximide-chase assay showing levels of Cln3-13Myc, Cln3-5A-13Myc, Cln3-3A-13Myc and Cln3-9A-13Myc after the addition of cycloheximide for the indicated number of minutes (min chx).
Benjamin D. Landry (149420)   +3 more
core   +1 more source

Cell cycle regulation of Cln3.

open access: yes, 2012
(A) Cln3 levels peak in mitosis. Cells expressing Cln3-13Myc were synchronized in G1 with alpha-factor and released into the cell cycle. Samples were collected for flow cytometry and Western blot analysis at 15-minute intervals.
Benjamin D. Landry (149420)   +3 more
core   +1 more source

Osmotic stress decreases the Golgi localization of myc-CLN3.

open access: yes, 2013
BHK clone 19 myc-CLN3-expressing cells were grown on poly-D-lysine coated coverslips either under isotonic (300 mOsm) or hyperosmotic conditions. Osmolarity was increased at 100 mOsm intervals to 800 mOsm by the addition of NaCl/urea. After being exposed
Amanda Getty (424612)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy